Skip to main content
Premium Trial:

Request an Annual Quote

Invitae to Raise $400M in Proposed Public Offering

NEW YORK – Invitae announced after the close of the market Wednesday that it aims to raise $400 million through an underwritten public offering of nearly 7.2 million shares of its common stock based on an assumed price of $55.86 per share.

The company estimated the number of shares it expects to sell based on the price of its common stock on the New York Stock Exchange on Jan. 19. Additionally, Invitae said it will give underwriters a 30-day option to purchase $60 million in additional shares of its common stock at the public offering price, minus underwriting discounts and expenses.

JP Morgan Securities, Morgan Stanley, Cowen, and SVB Leerink are acting as the book-running managers for the proposed offering.

Invitae plans to use the proceeds for working capital, improving its platform, expanding its oncology and reproductive testing products, and growing its international presence. A portion of the funds might also go toward acquiring other businesses and technologies.  

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.